Welcoming Stuart Blinkco as Chief Technology Officer at Nanophage Technologies

Nanophage Technologies is thrilled to be working with Dr Stuart Blincko, a diagnostics and R&D tour de force. 

With decades of experience in clinical diagnostics, assay development, and research leadership, Stuart brings invaluable expertise that will help drive further breakthroughs in diagnostic detection at Nanophage.

Stuart’s previous roles include being Senior Director leading the Clinical Diagnostics Division R&D at Thermo Fisher Scientific, Head of R&D at Immunodiagnostic Systems, Senior Director of Transfusion Diagnostics R&D at Immucor Inc., and Senior Principal Research Scientist at Abbott Diagnostics - among other impressive roles across both industry and academia.

We are delighted to have Stuart on board to further strengthen our technologies and customer understanding, and look forward to building on our current advances.